NIH-FDA analgesic drug development workshop: Translating scientific advances into improved pain relief

Clinical Journal of Pain

Volumn 19, Issue 3, 2003, Pages 139-147

  Dionne, Raymond A ^a   Witter, James ^b  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Analgesic drug development; Clinical analgesic trials; Pain

Indexed keywords

ANALGESIC AGENT; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

ANALGESIA; CANCER PAIN; CHILD CARE; CHILDHOOD DISEASE; CHRONIC PAIN; CLINICAL TRIAL; CONFERENCE PAPER; DRUG INDUSTRY; DRUG MECHANISM; DRUG RESEARCH; FIBROMYALGIA; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ORGANIZATION; HUMAN; LOW BACK PAIN; NECK PAIN; NEUROPATHIC PAIN; OSTEOARTHRITIS; OUTCOMES RESEARCH; PAIN ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; VISUAL ANALOG SCALE;

ANALGESICS; CLINICAL TRIALS; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); PAIN; QUALITY CONTROL; RESEARCH DESIGN; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0038663003     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002508-200305000-00001     Document Type: Conference Paper

References (2)

1. Foley KM, Gelband H (eds). Improving Palliative Care for Cancer. Washington, DC: National Academy Press; 2001.
2. Wolfe J, Grier HE, Klar N, et al. Symptoms and suffering at the end of life in children with cancer. N Engl J Med. 2000;342:326-33.